PROFUSE Trademark

Trademark Overview


On Wednesday, February 20, 2008, a trademark application was filed for PROFUSE with the United States Patent and Trademark Office. The USPTO has given the PROFUSE trademark a serial number of 77401115. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 27, 2015. This trademark is owned by Asterion Limited. The PROFUSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, medicaments in the form of topical creams and lotions, oral pills and tablets, and intravenous and intramuscular injections for the treatment of growth disorders, hematological disorders, metabolic disorders, autoimmune diseases, cancer and conditions associated with cancer, acromegaly, anemia, neutropenia, multiple sclerosis, rheumatoid arthritis or diabetes, bacterial or viral infectious or non infectious diseases, hepatitis and conditions associated with malnutrition, such as immune deficiency, tuberculosis, secondary amenorrhea and/or infertility; fungicides, herbicides; common cytokines including growth hormones, growth factors, interleukins, interferons, leptins, erythropoietins and tumor necrosis factors
profuse

General Information


Serial Number77401115
Word MarkPROFUSE
Filing DateWednesday, February 20, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 27, 2015
Registration Number3608233
Registration DateTuesday, April 21, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 3, 2009

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, medicaments in the form of topical creams and lotions, oral pills and tablets, and intravenous and intramuscular injections for the treatment of growth disorders, hematological disorders, metabolic disorders, autoimmune diseases, cancer and conditions associated with cancer, acromegaly, anemia, neutropenia, multiple sclerosis, rheumatoid arthritis or diabetes, bacterial or viral infectious or non infectious diseases, hepatitis and conditions associated with malnutrition, such as immune deficiency, tuberculosis, secondary amenorrhea and/or infertility; fungicides, herbicides; common cytokines including growth hormones, growth factors, interleukins, interferons, leptins, erythropoietins and tumor necrosis factors
Pseudo MarkPRO FUSE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAsterion Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSheffield S14DP
GB

Party NameAsterion Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSheffield S14DP
GB

Party NameAsterion Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSheffield S14DP
GB

Trademark Events


Event DateEvent Description
Friday, November 27, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, April 21, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, February 3, 2009PUBLISHED FOR OPPOSITION
Wednesday, January 14, 2009NOTICE OF PUBLICATION
Monday, December 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 26, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 17, 2008ASSIGNED TO EXAMINER
Tuesday, December 16, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 16, 2008ASSIGNED TO LIE
Tuesday, December 2, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 10, 2008NON-FINAL ACTION MAILED
Monday, June 9, 2008NON-FINAL ACTION WRITTEN
Monday, June 2, 2008ASSIGNED TO EXAMINER
Tuesday, February 26, 2008NOTICE OF PSEUDO MARK MAILED
Monday, February 25, 2008NEW APPLICATION ENTERED IN TRAM